Enovix Corp Earnings Per Share Disclosure
| Fiscal Years | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Numerator: | |||||||||||||||||
| Net loss attributable to common stockholders - basic | $ | (156,741) | $ | (222,241) | $ | (214,071) | |||||||||||
| Decrease in fair value of Private Placement Warrants | — | — | (6,180) | ||||||||||||||
| Net loss attributable to common stockholders - diluted | $ | (156,741) | $ | (222,241) | $ | (220,251) | |||||||||||
| Denominator: | |||||||||||||||||
Weighted-average shares outstanding used in computing net loss per share of common stock, basic (1) | 207,635,870 | 186,039,616 | 169,063,306 | ||||||||||||||
Dilutive effect of Private Placement Warrants | — | — | 509,858 | ||||||||||||||
Weighted-average shares outstanding used in computing net loss per share of common stock, diluted (1) | 207,635,870 | 186,039,616 | 169,573,164 | ||||||||||||||
Net loss per share of common stock: (1) | |||||||||||||||||
Basic | $ | (0.75) | $ | (1.19) | $ | (1.27) | |||||||||||
Diluted | (0.75) | (1.19) | (1.30) | ||||||||||||||
| Fiscal Years | ||||||||||||||
| 2024 | 2023 | |||||||||||||
| Numerators: | ||||||||||||||
| Net loss attributable to common stockholders, basic (as previously reported) | $ | (222,241) | $ | (214,071) | ||||||||||
| Decrease in fair value of Private Placement Warrants | — | (6,180) | ||||||||||||
| Net loss attributable to common stockholders, diluted (as previously reported) | (222,241) | (220,251) | ||||||||||||
| Fiscal Years | ||||||||||||||
| 2024 | 2023 | |||||||||||||
| Denominators: | ||||||||||||||
| Weighted-average shares outstanding used in computing net loss per share of common stock, basic (as previously reported) | 175,038,107 | 159,065,697 | ||||||||||||
| Effect of the Warrants | 11,001,509 | 9,997,609 | ||||||||||||
| Weighted-average shares outstanding used in computing net loss per share of common stock, basic (as adjusted) | 186,039,616 | 169,063,306 | ||||||||||||
| Weighted-average shares outstanding used in computing net loss per share of common stock, diluted (as previously reported) | 175,038,107 | 159,575,555 | ||||||||||||
| Effect of the Warrants | 11,001,509 | 9,997,609 | ||||||||||||
| Weighted-average shares outstanding used in computing net loss per share of common stock, diluted (as adjusted) | 186,039,616 | 169,573,164 | ||||||||||||
| Net loss per share of common stock: | ||||||||||||||
| Basic (as previously reported) | $ | (1.27) | $ | (1.35) | ||||||||||
| Basic (as adjusted) | (1.19) | (1.27) | ||||||||||||
| Diluted (as previously reported) | (1.27) | (1.38) | ||||||||||||
| Diluted (as adjusted) | (1.19) | (1.30) | ||||||||||||
| Fiscal Years | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Stock options outstanding | 1,206,554 | 1,751,118 | 2,615,199 | ||||||||||||||
| Restricted stock units and performance restricted stock units outstanding | 12,384,266 | 13,172,101 | 11,424,740 | ||||||||||||||
| Private Placement Warrants outstanding | 5,500,000 | 5,500,000 | — | ||||||||||||||
| Employee stock purchase plan estimated shares | 318,714 | 238,368 | 442,146 | ||||||||||||||
| Assumed conversion of Convertible Senior Notes | 20,318,538 | 11,053,800 | 11,053,800 | ||||||||||||||
Want the next Enovix Corp earnings per share disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Enovix Corp's next filing hits EDGAR. No credit card, your email never gets sold.
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.